azpa Weekly Update MultiBriefs
Contact Us
Media Kit

Browse Categories

Browse by Date

Stiff penalties put pressure on drug distributors

In recent years, the actions of pharmaceutical drug distributors have garnered mainstream attention. As the toll of the opioid abuse continues to be felt in the U.S., manufacturers, doctors and pharmacies are starting to experience the consequences of their unsanctioned,...

source: By Dr. Abimbola Farinde
Search past issues
Search products and services

Officials with the FDA have approved an Alkermes aripiprazole lauroxil (Aristada Initio) extended-release product for the treatment of schizophrenia in adults, according to the company. Aristada Initio leverages proprietary NanoCrystal technology, and the drug utilizes a...

source: Pharmacy Times

The Arizona Pharmacy Association Continuing Education Department is committed in offering high quality,...


The American Medical Association and other key stakeholders are calling for a coordinated effort to address a crippling nationwide shortage of drugs that include injectable opioid analgesics, IV fluids and Epi-pens.

source: HealthLeaders Media

For decades, our government has attempted to address one of the most pressing healthcare problems in our country — skyrocketing drug prices — to little avail. Recently, Secretary of Health and Human Services Alex Azar...

source: The Hill

When Amazon announced last week that it was buying the online pharmacy PillPack, it sent stocks of drugstore companies like Walgreens and Rite Aid tumbling, as investors worried that the retail behemoth would soon upend the pharmacy...

source: The New York Times


Powered by MultiBriefs
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063

Subscribe to AzPA Pharmacy Flash

*First Name:
*Last Name:
Street Address:
State / Province:
Zip / Postal Code:
Are you a member of AZPA? Yes   No
Privacy Policy